跳至主要内容
临床试验/IRCT201504251764N3
IRCT201504251764N3已完成2 期

Efficacy and safety of oral low dose ketamine for pediatric Intravenous cannulation

Vice chancellor for research,Tehran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 6 years(—)
性别
All

入选标准

  • children with no pain at baseline will enter the study? also children take part in the study who are able to take the drug orally.
  • Exclusion criteria: having any medical condition in which procedure is emergent and there is no 20-30 minutes chance to take analgesic; having any contraindication for prescribing ketamine (included but not limited to high blood pressure; high intracranial pressure; high intraocular pressure; Heart failure; Thyroid diseases; Respiratory system instability); the history of taking ketamine by patient in the last 24 hour in this center (in this study); 4. American Society of Anesthesiologists class= III; abnormal neurological exam; lack of parental consent; having any condition that makes evaluating pain difficult; Glasgow Coma Scale less than 15.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research,Tehran University of Medical Sciences

相似试验